Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
- PMID: 33907230
- PMCID: PMC8079688
- DOI: 10.1038/s41598-021-88428-9
Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
Abstract
Abnormalities in electroencephalographic (EEG) biomarkers occur in patients with schizophrenia and those clinically at high risk for transition to psychosis and are associated with cognitive impairment. Converging evidence suggests N-methyl-D-aspartate receptor (NMDAR) hypofunction plays a central role in the pathophysiology of schizophrenia and likely contributes to biomarker impairments. Thus, characterizing these biomarkers is of significant interest for early diagnosis of schizophrenia and development of novel treatments. We utilized in vivo EEG recordings and behavioral analyses to perform a battery of electrophysiological biomarkers in an established model of chronic NMDAR hypofunction, serine racemase knockout (SRKO) mice, and their wild-type littermates. SRKO mice displayed impairments in investigation-elicited gamma power that corresponded with reduced short-term social recognition and enhanced background (pre-investigation) gamma activity. Additionally, SRKO mice exhibited sensory gating impairments in both evoked-gamma power and event-related potential amplitude. However, other biomarkers including the auditory steady-state response, sleep spindles, and state-specific power spectral density were generally neurotypical. In conclusion, SRKO mice demonstrate how chronic NMDAR hypofunction contributes to deficits in certain translationally-relevant EEG biomarkers altered in schizophrenia. Importantly, our gamma band findings suggest an aberrant signal-to-noise ratio impairing cognition that occurs with NMDAR hypofunction, potentially tied to impaired task-dependent alteration in functional connectivity.
Conflict of interest statement
All authors except JTC and DTB declare no competing financial interests in relation to the work described. JTC reports holding a patent on D-serine to treat serious mental disorder that is owned by Massachusetts General Hospital but could yield royalties, and a patent on an AI-based EEG method to predict psychotropic drug response. DTB served as a consultant for LifeSci Capital and received research support from Takeda Pharmaceuticals.
Figures




Similar articles
-
Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction.J Neurophysiol. 2021 Jul 1;126(1):11-27. doi: 10.1152/jn.00661.2020. Epub 2021 May 26. J Neurophysiol. 2021. PMID: 34038186 Free PMC article.
-
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2400-9. doi: 10.1073/pnas.1304308110. Epub 2013 May 31. Proc Natl Acad Sci U S A. 2013. PMID: 23729812 Free PMC article.
-
Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.J Psychopharmacol. 2019 Oct;33(10):1288-1302. doi: 10.1177/0269881119856558. Epub 2019 Jul 11. J Psychopharmacol. 2019. PMID: 31294644
-
The origin of NMDA receptor hypofunction in schizophrenia.Pharmacol Ther. 2020 Jan;205:107426. doi: 10.1016/j.pharmthera.2019.107426. Epub 2019 Oct 16. Pharmacol Ther. 2020. PMID: 31629007 Free PMC article. Review.
-
Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia.Biol Psychiatry. 2016 May 1;79(9):716-726. doi: 10.1016/j.biopsych.2015.07.005. Epub 2015 Jul 17. Biol Psychiatry. 2016. PMID: 26281716 Free PMC article. Review.
Cited by
-
DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness.Mol Psychiatry. 2023 Nov;28(11):4553-4567. doi: 10.1038/s41380-023-02235-4. Epub 2023 Sep 7. Mol Psychiatry. 2023. PMID: 37679470 Free PMC article. Review.
-
Auditory evoked-potential abnormalities in a mouse model of 22q11.2 Deletion Syndrome and their interactions with hearing impairment.Transl Psychiatry. 2025 Jan 8;15(1):4. doi: 10.1038/s41398-024-03218-x. Transl Psychiatry. 2025. PMID: 39779687 Free PMC article.
-
Serine racemase deletion alters adolescent social behavior and whole-brain cFos activation.Front Psychiatry. 2024 Jun 24;15:1365231. doi: 10.3389/fpsyt.2024.1365231. eCollection 2024. Front Psychiatry. 2024. PMID: 38979499 Free PMC article.
-
Gamma frequency connectivity in frontostriatal networks associated with social preference is reduced with traumatic brain injury.Netw Neurosci. 2024 Dec 10;8(4):1634-1653. doi: 10.1162/netn_a_00416. eCollection 2024. Netw Neurosci. 2024. PMID: 39735516 Free PMC article.
-
Subcortical control of the default mode network: Role of the basal forebrain and implications for neuropsychiatric disorders.Brain Res Bull. 2022 Jul;185:129-139. doi: 10.1016/j.brainresbull.2022.05.005. Epub 2022 May 11. Brain Res Bull. 2022. PMID: 35562013 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases